Clinical Implications of the Updated Efficacy Results of the INDIGO Trial: Vorasidenib vs. Placebo in Patients With Adult-Type Diffuse Glioma With an IDH1/2 Mutation | VuMedi

Find latest Central Nervous System videos · 200+ videos

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

10 seconds

Playback speed

Clinical Implications of the Updated Efficacy Results of the INDIGO Trial: Vorasidenib vs. Placebo in Patients With Adult-Type Diffuse Glioma With an IDH1/2 Mutation

By Riccardo Soffietti

76 views

February 14, 2025

Comments 0

Login to view comments. Click here to Login